Right BACH2 at you @roychoudhurilab.bsky.social 😆
Fantastic to see research on BACH2 from former #ListerFellow Rahul Roychoudhuri and colleagues included in Nature News and Views.
Read the paper on fine-tuning BACH2 dosage to enhance antitumor T cell therapy⤵️
www.nature.com/articles/s41...
One of three back-to-back papers to show dosage of BACH2 can modulate T cell differentiation and function and how we might apply this to enhance chimeric antigen receptor T cell therapies for cancer.
Great News&Views piece covering the three papers on BACH2 dosing recently published in @natimmunol.nature.com
Love the title: BACH2 the future!
www.nature.com/articles/s41...